Journal of vascular and interventional radiology : JVIR
-
J Vasc Interv Radiol · Apr 2006
Randomized Controlled Trial Comparative StudyComparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization.
The primary purpose of the present study was to compare the antiinflammatory effectiveness of rofecoxib with that of ibuprofen in the first 5 days after uterine artery embolization (UAE). The secondary aim was to compare pain levels and narcotic use among patients treated with different embolic agents. ⋯ There was no difference between rofecoxib and ibuprofen with respect to postprocedural pain or narcotic use after UAE. Embolic agent appeared to have a greater impact, with patients in the Embosphere Gold group reporting higher pain scores and those in the Contour SE group requiring a lower amount of narcotic drug than those in the Embosphere Gold or Embosphere groups.